Milk Polar Lipids for Abdominal Obesity
Trial Summary
What is the purpose of this trial?
The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications. The trial excludes people taking lipid-lowering medications, anti-inflammatory medications, and medications that affect blood clotting.
What data supports the effectiveness of the treatment Milk Polar Lipids for Abdominal Obesity?
Research shows that milk polar lipids, particularly those in the milk fat globule membrane (MFGM), have antioxidant and anti-inflammatory properties, which may help improve metabolic health. Additionally, MFGM has been shown to support cognitive development in infants and reduce colon cancer markers in rats, suggesting potential health benefits that could extend to managing abdominal obesity.12345
Is Milk Polar Lipids treatment safe for humans?
Milk Polar Lipids, found in milk fat globule membranes (MFGM), have been used in various products like infant formula and are generally considered safe. Studies have shown positive effects on cognitive and immune health, and they have antioxidant and anti-inflammatory properties, suggesting they are safe for human consumption.12467
How is the Milk Polar Lipid-Rich Dairy Powder treatment unique for abdominal obesity?
Milk Polar Lipid-Rich Dairy Powder is unique because it contains milk polar lipids, which have been shown to potentially improve gut health and reduce inflammation, factors that can contribute to obesity. Unlike other treatments, it leverages the natural properties of milk fat globule membrane components, which may help modulate gut bacteria and prevent weight gain in high-fat diets.148910
Eligibility Criteria
This trial is for adults aged 40 to 70 with high LDL cholesterol (bad cholesterol) and a large waistline, indicating abdominal obesity. It's not suitable for individuals with gallbladder, thyroid, gut diseases, autoimmune or chronic inflammatory conditions, diabetes, recent antibiotic use, milk allergies/intolerances, or those on certain medications like statins.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume either a control dairy beverage or an MPL-rich dairy beverage daily
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Dairy Powder
- Milk Polar Lipid-Rich Dairy Powder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Connecticut
Lead Sponsor
Dairy Management Inc.
Industry Sponsor